FIIs hike shareholding in Lupin to 28.8% in March 2013 quarter

12 Apr 2013 Evaluate

Foreign institutional investors (FIIs) have hiked their shareholding in pharma major, Lupin, to historic highs of 28.8% in March 2013 quarter from 27.76% at the end of December 2012 quarter. FIIs bought 4.66 million shares worth of Rs 279 crore in January-March quarter.

Lupin is the 5th largest and fastest growing generics player in the US (5.1% market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical company by sales. The company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS).

Lupin Share Price

2071.35 -26.30 (-1.25%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×